Sophie Park

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

Sophie Park, Sophie Grabar, Charikleia Kelaïdi et al. · Blood · 2007 · 328 citations · Full text

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

John Koreth, Joseph Pidala, Waleska S. Pérez et al. · Journal of Clinical Oncology · 2013 · 282 citations · Full text

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways

Jérôme Tamburini, Nicolas Chapuis, Valérie Bardet et al. · Blood · 2007 · 252 citations

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

Frédérik Damm, Virginie Chesnais, Yasunobu Nagata et al. · Blood · 2013 · 215 citations

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

Gandhi Damaj, Alain Duhamel, Marie Robin et al. · Journal of Clinical Oncology · 2012 · 204 citations · Full text